Phase 1 study builds on early signals of anti-tumor activity in patients with refractory T and B cell lymphomasIpsoprubart, a first-in-class ...
On the heels of FDA’s clearance, the company plans to begin a Phase Ib/IIa trial evaluating CK0802 in patients who have ...
In the ARES trial, MaaT013 led to improvement in refractory lower GI chronic GVHD, a key unmet need in patients receiving ...
Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced the presentation of updated data from its Phase 1 trial of ...
Stereotactic arrhythmia radioablation reduces sustained ventricular tachycardia episodes and defibrillator shocks in patients with treatment-refractory disease, without treatment related deaths.
Eptinezumab is associated with modest reductions in headache frequency for patients with chronic migraine with inadequate ...
Proton beam therapy, a radiation treatment for cancer, may be effective as a treatment for refractory ventricular tachycardia ...
The experimental drug erenumab (AMG 334, Amgen and Novartis) is effective and safe in patients with episodic migraine in whom previous treatments have failed, results of a new phase 3b trial have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results